Historical analysis of Regeneron Pharmaceuticals income statement accounts such as can show how well Regeneron Pharmaceuticals performed in making a profits. Evaluating Regeneron Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Regeneron Pharmaceuticals future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Regeneron Pharmaceuticals latest accounting reports in order to predict its past. Macroaxis encourages investors to analyze financial statement over time for various trends across multiple indicators and accounts to determine whether Regeneron Pharmaceuticals is a good buy for the upcoming year. Additionally take a look at Your Equity Center.
Consolidated IncomeThe portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].
Cost of RevenueCost of Revenue is found on Regeneron Pharmaceuticals income statement and represents the costs associated with goods and services Regeneron Pharmaceuticals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. The aggregate cost of goods produced and sold and services rendered during the reporting period.
Earning Before Interest and Taxes USDEarning Before Interest and Taxes EBIT in USD; converted by [FXUSD].
Gross ProfitGross profit is a required income statement account that reflects total revenue of Regeneron Pharmaceuticals minus its cost of goods sold. It is profit before Regeneron Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. Aggregate revenue [Revenue] less cost of revenue [CoR] directly attributable to the revenue generation activity.
Interest ExpenseAmount of the cost of borrowed funds accounted for as interest expense.
Net Income Common StockThe amount of net income (loss) for the period due to common shareholders. Typically differs from [NetInc] to the parent entity due to the deduction of [PrefDivIS].
Net Income Common Stock USD[NetIncCmn] in USD; converted by [FXUSD].
Operating ExpensesOperating expenses represents the total expenditure on [SGnA]; [RnD] and other operating expense items; it excludes [CoR].
Operating IncomeOperating Income is the amount of profit realized from Regeneron Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Regeneron Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Operating income is a measure of financial performance before the deduction of [IntExp]; [TaxExp] and other Non-Operating items. It is calculated as Gross Profit minus [OpEx].
RevenuesRevenues refers to the total amount of money received by Regeneron Pharmaceuticals for goods sold or services provided during a certain time period. It also includes all of Regeneron Pharmaceuticals sales as well as any other increase in Regeneron Pharmaceuticals equity.Revenues are reported on Regeneron Pharmaceuticals income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
Revenues USD[Revenue] in USD; converted by [FXUSD].
Research and Development ExpenseA component of [OpEx] representing the aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service.
Selling General and Administrative ExpenseA component of [OpEx] representing the aggregate total costs related to selling a firm's product and services; as well as all other general and administrative expenses. Direct selling expenses (for example; credit; warranty; and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products; for example telephone expenses; Internet; and postal charges. General and administrative expenses include salaries of non-sales personnel; rent; utilities; communication; etc.
Weighted Average SharesThe weighted average number of shares or units issued and outstanding that are used by the company to calculate Earnings per Basic Share; determined based on the timing of issuance of shares or units in the period.
Weighted Average Shares DilutedThe weighted average number of shares or units issued and outstanding that are used by the company to calculate [EPSDil]; determined based on the timing of issuance of shares or units in the period.
Income Tax ExpenseAmount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.